Special Lecture9
- Effort of JPMA for Open InnovationMitsubishi Tanabe Pharma Corporation
Company-Organized Symposium
Initiatives for the development and commercialization of innovations originated from universities
- Current status of drug development in Tohoku University Hospital (CRIETO).Tohoku University Hospital
- Medical Development Efforts at the iACTDept. Medical Development, iACT, Kyoto Univ. Hosp.
- First in human and investigator-initiated clinical trial of an anticancer drug targeted on a new amino acid transporter1Dept. Gastroenterology and Hepatology, Osaka Univ., 2Dept. Medical Innovation, Osaka Univ. Hosp., 3Fac. Pharmacy, Kanazawa Univ., 4Dept. Laboratory Medicine, The Jikei Univ, 5Dept. Bio-system Pharmacology, Osaka Univ.
- Development of therapeutic vaccine in academiaDepartment of Health Development and Medicine, Osaka University Graduate School of Medicine
The 8th Japan-China Joint Meeting of Basic and Clinical Pharmacology
- Networks of organelle function in cardiovascular diseasesDept. Pharmacol., Coll. Pharm., Harbin Med. Univ.
- Redox regulation of mitochondrial quality as a therapeutic target of cardiac senescenceGrad. Sch. Pharm. Sci., Kyushu Univ. / NIPS
- Application of Clinical Pharmacology in Early Clinical Drug Development: PK/PD studies of a new proton pump inhibitorClin. Pharm. Res. Cent., Peking Union Med. Coll. Hosp.
- Development of endogenous biomarkers to assess drug-transporter-mediated drug-drug interactions in drug developmentGrad. Sch. Pharm. Sci., Univ. Tokyo
